Lennart Opitz

Lennart Opitz

Auto-generated profile, based on publicly available information

Lennart Opitz

DNA Microarray Facility, Department of Developmental Biochemistry, University of Göttingen, Humboldtallee 23, 37073, Göttingen, Germany

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2009 in Molecular Neurodegeneration
Verified
Journal Article
Open access
PDF file
JMJudith Montag
Judith Montag
RHReiner Hitt
Reiner Hitt
LOLennart Opitz
Lennart Opitz
WSWalter Schulz-Schaeffer
Walter Schulz-Schaeffer
GHGerhard Hunsmann
Gerhard Hunsmann
DMDirk Motzkus
Dirk Motzkus
The aim of our study was to analyze the differential expression of miRNAs in the brains of BSE-infected cynomolgus macaques as a model for Creutzfeldt-Jakob disease (CJD). MicroRNAs (miRNAs) are small noncoding RNAs regulating gene expression by mRNA targeting. Among other functions they contribute to neuronal development and survival. Recently, the lack of miRNA processing has been shown to promote neurodegeneration and deregulation of several miRNAs has been reported to be associated with Scrapie in mice. Therefore, we hypothesized that miRNAs are also regulated in response to human prion disease. We have applied miRNA-microarrays to identify deregulated miRNA candidates in brains of BSE-infected macaques. Shock-frozen brain sections of six BSE-infected and five non-infected macaques were used to validate regulated miRNA candidates by two independent qRT-PCR-based methods. Our study revealed significant upregulation of hsa-miR-342-3p and hsa-miR-494 in the brains of BSE-infected macaques compared to non-infected animals. In a pilot study we could show that hsa-miR-342-3p was also upregulated in brain samples of human type 1 and type 2 sporadic CJD. With respect to the reported regulation of this miRNA in Scrapie-infected mice, we propose that upregulation of hsa-miR-342-3p may be a general phenomenon in late stage prion disease and might be used as a novel marker for animal and human TSEs.

25 April 2008 in BMC Neuroscience
Verified
Journal Article
Open access
PDF file
AKAngelika Kippert
Angelika Kippert
KTKatarina Trajkovic
Katarina Trajkovic
DFDirk Fitzner
Dirk Fitzner
LOLennart Opitz
Lennart Opitz
MSMikael Simons
Mikael Simons
Background: During the development of the central nervous system, oligodendrocytes generate large amounts of myelin, a multilayered insulating membrane that ensheathes axons, thereby allowing the fast conduction of the action potential and maintaining axonal integrity. Differentiation of oligodendrocytes to myelin-forming cells requires the downregulation of RhoA GTPase activity.Results: To gain insights into the molecular mechanisms of oligodendrocyte differentiation, we performed microarray expression profiling of the oligodendroglial cell line, Oli-neu, treated with the Rho kinase (ROCK) inhibitor, Y-27632 or with conditioned neuronal medium. This resulted in the identification of the transmembrane protein 10 (Tmem10/Opalin), a novel type I transmembrane protein enriched in differentiating oligodendrocytes. In primary cultures, Tmem10 was abundantly expressed in O4-positive oligodendrocytes, but not in oligodendroglial precursor cells, astrocytes, microglia or neurons. In mature oligodendrocytes Tmem10 was enriched in the rims and processes of the cells and was only found to a lesser extent in the membrane sheets.Conclusion: Together, our results demonstrate that Tmem10 is a novel marker for in vitro generated oligodendrocytes.

1 January 2012 in Nutrition & Metabolism
Verified
Journal Article
Open access
PDF file
CFCarolin Fromm-Dornieden
Carolin Fromm-Dornieden
OLOleksandr Lytovchenko
Oleksandr Lytovchenko
SHSilvia von der Heyde
Silvia von der Heyde
NBNina Behnke
Nina Behnke
SHSebastian Hogl
Sebastian Hogl
BBBernhard G Baumgartner
Bernhard G Baumgartner
DOR/TP53INP2 acts both at the chromosomal level as a nuclear co-factor e.g. for the thyroid hormone receptor and at the extrachromosomal level as an organizing factor of the autophagosome. In a previous study, DOR was shown to be down-regulated in skeletal muscle of obese diabetic Zucker fa/fa rats.